| [1] |
Elliott P M, Anastasakis A, Borger M A , et al. 2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the task force for the diagnosis and management of hypertrophic cardiomyopathy of the European Society of Cardiology (ESC)[J]. Eur Heart J, 2014,35(39):2733-2779.
doi: 10.1093/eurheartj/ehu284
pmid: 25173338
|
| [2] |
Maron B J, Mckenna W J, Danielson G K , et al. American College of Cardiology/European Society of Cardiology clinical expert consensus document on hypertrophic cardiomyopathy: a report of the American College of Cardiology Foundation Task Force on clinical expert consensus documents and the European Society of Cardiology Committee for practice guidelines[J]. Eur Heart J, 2003,24(21):1965-1991.
doi: 10.1016/s0195-668x(03)00479-2
pmid: 14585256
|
| [3] |
Gersh B J, Maron B J, Bonow R O , et al. 2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines[J]. J Am Coll Cardiol, 2011,58(25):2703-2738.
doi: 10.1016/j.jacc.2011.10.825
pmid: 22075468
|
| [4] |
Maron B J, Gardin J M, Flack J M , et al. Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Echocardiographic analysis of 4 111 subjects in the CARDIA study. Coronary artery risk development in (young) adults[J]. Circulation, 1995,92(4):785-789.
doi: 10.1161/01.cir.92.4.785
pmid: 7641357
|
| [5] |
Zou Y, Song L, Wang Z , et al. Prevalence of idiopathic hypertrophic cardiomyopathy in China: a population-based echocardiographic analysis of 8 080 adults[J]. Am J Med, 2004,116(1):14-18.
doi: 10.1016/j.amjmed.2003.05.009
pmid: 14706660
|
| [6] |
Maron B J, Olivotto I, Spirito P , et al. Epidemiology of hypertrophic cardiomyopathy related death: revisited in a large non-referral-based patient population[J]. Circulation, 2000,102(8):858-864.
doi: 10.1161/01.cir.102.8.858
pmid: 10952953
|
| [7] |
O'mahony C, Jichi F, Pavlou M , et al. A novel clinical risk prediction model for sudden cardiac death in hypertrophic cardiomyopathy (HCM risk-SCD)[J]. Eur Heart J, 2014,35(30):2010-2020.
doi: 10.1093/eurheartj/eht439
|
)
